Skip to main content
1999Dr. Landherr LászlóEgyébTudományos anyagok

Gastrointestinalis tumorok – Dr. Landherr László

By 2018.01.03.április 3rd, 2024Nincsenek hozzászólások
06LADHER-1999.pdf

 

Irodalom

  1. Abdel-Wahab M. El-Shennawy F. Agha S. Ragab E. Fathi O. Sultan A. Elghawalby N. Ezzat F.: Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2). Hepato-Gastroenterology. 46 Suppl 1:1293-6, 1999 May.
  2. Barton MB. Kneebone AB.: Adjuvant therapy for rectal cancer can no longer be ignored. Australian & New Zealand Journal of Surgery. 69(9):619-21, 1999 Sep.
  3. Berlin J. Merrick HW. Smith TJ.: Lerner H Phase II evaluation of treatment of complete resection of hepatic metastases from colorectal cancer and adjuvant hepatic arterial infusion of floxuridine: an Eastern Cooperative Oncology Group Study (PB083). American Journal of Clinical Oncology. 22(3):291-3, 1999 Jun.
  4. Bleiberg H.: CPT-11 in gastrointestinal cancer. [Review][85 refs] European Journal of Cancer. 35(3):371-9, 1999 Mar.
  5. Bozzetti F. Baratti D. Andreola S. Zucali R. Schiavo M. Spinelli P. Gronchi A. Bertario L. Mariani L. Gennari L.: Preoperative radiation therapy for patients with T2-T3 carcinoma of the middle-to-lower rectum. Cancer. 86(3):398-404, 1999 Aug 1.
  6. Cassidy J.: Potential of Xeloda in colorectal cancer and other solid tumors. [Review] [26 refs] Oncology. 57 Suppl 1:27-32, 1999 Jul.
  7. Cerottini JP. Caplin S. Pampallona S. Givel JC.: Prognostic factors in colorectal cancer. Oncology Reports. 6(2):409-14, 1999 Mar-Apr.
  8. Cunningham D.: Setting a new standard–irinotecan (Campto) in the second-line therapy of colorectal cancer: final results of two phase III studies and implications for clinical practice. [Review] [29 refs] Seminars in Oncology. 26(1 Suppl 5):1-5, 1999 Feb.
  9. Eriguchi N. Aoyagi S. Fukuda S. Hara M. Imamura I. Hashino K. Hashimoto M. Tanaka E. Tanaka M.: A long-term survival patient with advanced gallbladder cancer massively metastasizing to the liver. [Review] [17 refs] Kurume Medical Journal. 46(1):83-6, 1999.
  10. Faivre J. Bonithon-Kopp C.: Chemoprevention of colorectal cancer. [Review] [25 refs] Recent Results in Cancer Research. 151:122-33, 1999
  11. Fata F. Ron IG. Kemeny N. O’Reilly E. Klimstra D. Kelsen DP.: 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer. 86(7):1129-34, 1999 Oct 1.
  12. Ferreri AJ. Cordio S. Ponzoni M. Villa E.: Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage I-II high-grade gastric lymphoma. Leukemia & Lymphoma. 33(5-6):531-41, 1999 May.
  13. Fountzilas G. Zisiadis A. et al.: Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group. Annals of Oncology. 10(6):671-6, 1999 Jun.
  14. Grodstein F. Newcomb PA. Stampfer MJ.: Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. American Journal of Medicine. 106(5):574-82, 1999 May.
  15. Groen KA.: Primary and metastatic liver cancer. [Review] [55 refs] O’Connor KG.: Gastric cancer. [Review] [41 refs] Seminars in Oncology Nursing. 15(1):26-35, 1999 Feb.
  16. Gunderson LL. Haddock MG. Burch P. Nagorney D. Foo ML. Todoroki T.: Future role of radiotherapy as a component of treatment in biliopancreatic cancers. [Review] [30 refs] Annals of Oncology. 10 Suppl 4:291-5, 1999.
  17. Gunderson LL.: Indications for and results of combined modality treatment of colorectal cancer [see comments]. [Review] [52 refs] Acta Oncologica. 38(1):7-21, 1999.
  18. Hanazaki K. Mochizuki Y. Machida T. Yokoyama S. Sodeyama H. Sode Y. Wakabayashi M. Kawamura N. Miyazaki T.: Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer. Hepato-Gastroenterology. 46(26):1238-43, 1999 Mar-Apr.
  19. Janjan NA. Abbruzzese J. Pazdur R. Khoo VS. Cleary K. Dubrow R. Ajani J. Rich TA. Goswitz MS. Evetts PA. Allen PK. Lynch PM. Skibber JM.: Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiotherapy & Oncology. 51(2):153-60, 1999 May.
  20. Kainuma O. Asano T. Aoyama H. Takayama W. Nakagohri T. Kenmochi T. Hasegawa M. Tokoro Y. Sasagawa S. Ochiai T.: Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer. Hepato-Gastroenterology. 46(26):1071-7, 1999 Mar-Apr.
  21. Kolh P. Honore P. Gielen JL. Degauque C. Azzam C. Legrand M. Jacquet N.: Analysis of factors influencing long-term survival after surgical resection for oesophageal squamous cell carcinoma. Acta Chirurgica Belgica. 99(3):113-8, 1999 May-Jun.
  22. Konno H. Tanaka T. Baba M. Kanai T. Nakamura S.: Antiangiogenic therapy for liver metastasis of gastrointestinal malignancies. (Review) (30 refs) Journal of Hepato-Biliary-Pancreatic Surgery. 6(1):1-6, 1999.
  23. Lehnert T.: Multimodal therapy for squamous carcinoma of the oesophagus. [Review] [69 refs] British Journal of Surgery. 86(6):727-39, 1999 Jun.
  24. Leichman CG. Jacobson JR. Modiano M. Daniels JR. Zalupski MM. Doroshow JH. Fletcher WS. Macdonald JS.: Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial. Cancer. 86(5):775-81, 1999 Sep 1.
  25. Litvak DA. Papaconstantinou HT. Hwang KO. Kim M. Evers BM. Townsend CM Jr.: Inhibition of gastric cancer by camptothecin involves apoptosis and multiple cellular pathways. Surgery. 126(2):223-30, 1999 Aug.
  26. Madura JA. Jarman BT. Doherty MG. Yum MN. Howard TJ. Adenosquamous carcinoma of the pancreas. [Review] [36 refs] Archives of Surgery. 134(6):599-603, 1999 Jun.
  27. Makrauer FL. Oates E. Becker J. Abrams R. O’Connor T. McCallum R. Shumaker J.: Does local irradiation affect gastric emptying in humans?. American Journal of the Medical Sciences. 317(1):33-7, 1999 Jan.
  28. Mannaerts GH. Martijn H. Crommelin MA. Stultiens GN. Dries W. van Driel OJ. Rutten HJ.: Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 45(2):297-308, 1999 Sep 1.
  29. Martenson JA. Shanahan TG. O’Connell MJ. Cobau CD. Schroeder G. Burch PA. Levitt R. Rowland KM Jr.: Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy. Cancer. 86(4):710-4, 1999 Aug 15.
  30. Midgley R. Kerr D.: Colorectal cancer. Lancet. 353(9150):391-9, 1999 Jan 30.Newcomb PA. Taylor JO. Trentham-Dietz A.: Interactions of familial and hormonal risk factors for large bowel cancer in women. International Journal of Epidemiology. 28(4):603-8, 1999 Aug.
  31. Minsky BD.: Adjuvant postoperative combined-modality therapy for rectal cancer. [Review] [33 refs] Oncology. 13(7 Suppl 3):132-5, 1999 Jul.
  32. Nakajima T. Nashimoto A. Kitamura M. Kito T. Iwanaga T. Okabayashi K. Goto M.: Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group. Lancet. 354(9175):273-7, 1999 Jul 24.
  33. Nijsen JF. Zonnenberg BA. Woittiez JR. Rook DW. Swildens-van Woudenberg IA. van Rijk PP. van het Schip AD.: Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques. European Journal of Nuclear Medicine. 26(7):699-704, 1999 Jul.
  34. Peeters M. Haller DG.: Therapy for early-stage colorectal cancer. [Review] [45 refs] Oncology. 13(3):307-15; discussion 315-7, 320-1, 1999 Mar.
  35. Roukos DH. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. [Review] [86 refs] Annals of Surgical Oncology. 6(1):46-56, 1999 Jan-Feb.Seminars in Oncology. 26(1 Suppl 5):1-5, 1999 Feb.
  36. Royce ME. Pazdur R.: Novel chemotherapeutic agents for gastrointestinal cancers. [Review] [63 refs] Current Opinion in Oncology. 11(4):299-304, 1999 Jul.
  37. Safran H. Akerman P. Cioffi W. Gaissert H. Joseph P. King T. Hesketh PJ. Wanebo H.: Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction. Seminars in Radiation Oncology. 9(2 Suppl 1):53-7, 1999 Apr.
  38. Sporn JR.: Practical recommendations for the management of adenocarcinoma of the pancreas. [Review] [48 refs] Drugs. 57(1):69-79, 1999 Jan.
  39. Stein U. Rau B. Wust P. Walther W. Schlag PM.: Hyperthermia for treatment of rectal cancer: evaluation for induction of multidrug resistance gene (mdr1) expression. International Journal of Cancer. 80(1):5-12, 1999 Jan 5.
  40. Stucky-Marshall L.: New agents in gastrointestinal malignancies: Part 1: Irinotecan in clinical practice. [Review] [22 refs] Cancer Nursing. 22(3):212-9, 1999 Jun.
  41. Todoroki T. Kawamoto T. Otsuka M. Koike N. Yoshida S. Takada Y. Adachi S. Kashiwagi H. Fukao K. Ohara K.: Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer. Hepato-Gastroenterology. 46(27):1585-91, 1999 May-Jun.
  42. Van Cutsem E. Peeters M.: Developments in fluoropyrimidine therapy for gastrointestinal cancer. [Review] [44 refs] Current Opinion in Oncology. 11(4):312-7, 1999 Jul.
  43. Varma MG. Rogers SJ. Schrock TR. Welton ML.: Local excision of rectal carcinoma. Archives of Surgery. 134(8):863-7; discussion 867-8, 1999 Aug.
  44. Wagman R. Minsky BD. Cohen AM. Saltz L. Paty PB. Guillem JG. : Conservative management of rectal cancer with local excision and postoperative adjuvant therapy. International Journal of Radiation Oncology, Biology, Physics. 44(4):841-6, 1999 Jul 1.
  45. Willett CG. Badizadegan K. Ancukiewicz M. Shellito PC.: Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy?. Diseases of the Colon & Rectum. 42(2):167-73, 1999 Feb.
  46. Wiseman LR. Adkins JC. Plosker GL. Goa KL.: Oxaliplatin: a review of its use in the management of metastatic colorectal cancer. [Review] [89 refs] Drugs & Aging. 14(6):459-75, 1999 Jun.
  47. Worthington TR. Williamson RC.: The continuing challenge of exocrine pancreatic cancer. Comprehensive Therapy. 25(6-7):360-5, 1999 Jun-Jul.
  48. Yoon SS. Tanabe KK.: Surgical treatment and other regional treatments for colorectal cancer liver metastases. [Review] [102 refs]Journal of Hazardous Materials. 4(3):197-208, 1999